Stephenson Cancer Center in Oklahoma City: Academic Research Hospital with Immediate-Access Clinical Trials
OU Health's Stephenson Cancer Center is a National Cancer Institute-designated academic medical center that treats more than 6,000 active cancer patients annually and operates Oklahoma's primary source of Phase 1 through Phase 4 clinical trials in oncology. Unlike community oncology practices, Stephenson functions as both a treatment hospital and a research facility, meaning that access to newer drug combinations and immunotherapy protocols not yet in standard practice happens here first, often at no additional cost to patients enrolled in trials.
What Stephenson Cancer Center Actually Is
Stephenson Cancer Center is housed within OU Medical Center on Stanton L. Young Boulevard and serves as the state's NCI-designated Comprehensive Cancer Center. This classification means the institution is required to meet federal standards for integrated research, education, and clinical care. It is not a specialty clinic; it is a full-service hospital with dedicated oncology inpatient and outpatient space. Patients range from those seeking a second opinion before standard chemotherapy to those with rare cancers or drug-resistant disease seeking enrollment in experimental trials.
The center occupies 100,000 square feet across three floors, with separate areas for hematologic malignancies, solid tumors, pediatric oncology, bone marrow transplantation, and supportive care. It functions as both a safety net for uninsured or underinsured Oklahomans and a referral destination for out-of-state patients seeking access to trials unavailable elsewhere.
Services and Cost Structure
Stephenson provides surgery, chemotherapy, radiation therapy, immunotherapy, hormone therapy, targeted molecular therapy, stem cell and bone marrow transplantation, and palliative care. Many services are available through standard insurance; however, the practical advantage of Stephenson lies in clinical trial enrollment. Patients in Phase 1 and Phase 2 trials typically receive study drugs at no cost. Phase 3 and Phase 4 trials follow standard insurance billing once the patient meets enrollment criteria.
For uninsured patients, OU Health operates a hospital financial assistance program that can reduce or eliminate bills based on household income. Specific copay or deductible amounts depend on the patient's insurance plan and the specific treatment chosen; ask for an estimate from the financial counselor before treatment begins.
Outpatient consultation rates for oncologists are typically $200 to $350 for a new patient, though insurance often covers this. Inpatient bone marrow transplantation can exceed $200,000 total cost, but financial counseling specifically addresses transplant funding and payment plans.
How Stephenson Compares to Other Oklahoma City Cancer Care Options
Community oncology practices in Oklahoma City such as those within Integris or Mercy Health Systems handle standard chemotherapy and radiation in smaller clinic settings without on-site research. These are appropriate for patients with common cancers (breast, colon, lung) and standard treatment plans who value shorter wait times and closer location to home.
Stephenson differs in three ways. First, it holds active Phase 1 and Phase 2 trials, meaning patients with disease resistant to standard therapy have access to experimental drugs not available in community clinics. Second, it conducts molecular testing in-house, allowing faster identification of genomic mutations that direct treatment choice. Third, it maintains inpatient bone marrow transplant capacity, which no other Oklahoma institution offers.
Choose Stephenson if you have a rare cancer, refractory disease, or strong interest in clinical trial participation. Choose a community oncology practice if you have early-stage common cancer, live far from Oklahoma City, or want minimal travel burden.
Who Stephenson Suits and Who It Does Not
Stephenson is best suited to patients with Stage 3 or 4 disease, rare cancers, previous treatment failure, or specific genetic mutations requiring specialized drugs. It is also appropriate for any patient who wishes to consult at an NCI-designated center before making treatment decisions. Pediatric patients with cancer, though rare, are seen here.
Stephenson is not a practical choice for patients requiring daily outpatient chemotherapy who live more than 30 minutes away, because the drive burden outweighs the benefit of an academic center for uncomplicated cases. It is also not appropriate for palliative care without active treatment; hospice organizations and community practices handle end-of-life care more flexibly.
What the First Visit Involves
New patients schedule a consultation with an oncologist. Bring all prior imaging (CT, MRI, PET scans), pathology reports, and records from any previous treatment. The oncologist will review your history, order staging scans if not recent, and discuss treatment options. Genetic testing may be ordered on the same day or at a follow-up visit.
If clinical trial enrollment is possible, the research team will explain the trial protocol, including schedule, duration, side effects, and the process for withdrawing. Informed consent is required and takes 30 to 60 minutes. Financial counseling is offered before the first treatment begins.
Hours, Parking, and Logistics
The main campus operates Monday through Friday, 7 a.m. to 5 p.m. for most outpatient oncology. Inpatient services operate 24/7. The center is located at 800 N.E. 10th Street, part of the OU Medical Center complex. Covered parking is available; validate at the information desk. Confirm current hours online before your appointment, as specialty clinics (pediatric, transplant) may vary.
Stephenson Cancer Center draws patients from across Oklahoma and neighboring states because clinical trial access and NCI designation are unavailable elsewhere in the region.
